Quince Therapeutics

Quince TherapeuticsQuince Therapeutics
Quince Therapeutics

Quince Therapeutics

A biopharmaceutical company focused on developing novel therapies.

2020Active
Rate

About

Quince Therapeutics, Inc. is a biopharmaceutical company. The company is focused on the development and commercialization of novel therapies. They recently announced the settlement of outstanding obligations under a loan from the European Investment Bank (EIB), a significant milestone that allows them to advance their restructuring and explore strategic alternatives to maximize shareholder value.

Technology stack

detected 2026-06-23
EmailMicrosoft 365
Hosting
AWS
Stack
jQueryWordPress
Analytics
Jetpack / WP.com Stats
Video
Vimeo
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Quince Therapeutics do?

Quince Therapeutics, Inc. is a biopharmaceutical company. The company is focused on the development and commercialization of novel therapies. They recently announced the settlement of outstanding obligations under a loan from the European Investment Bank (EIB), a significant milestone that allows them to advance their restructuring and explore strategic alternatives to maximize shareholder value.

How much funding has Quince Therapeutics raised?

Quince Therapeutics has raised a total of $63M in funding. The most recent round on record is Series C.

Where is Quince Therapeutics headquartered?

Quince Therapeutics is headquartered in South San Francisco, California, USA.

When was Quince Therapeutics founded?

Quince Therapeutics was founded in 2020.

What industry does Quince Therapeutics operate in?

Quince Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare.

What is Quince Therapeutics's revenue?

StartupHub estimates Quince Therapeutics's annual revenue at $80.3M (range $37.9M to $136.2M, 44% confidence), based on comparable companies in the sector.

What is Quince Therapeutics's valuation?

StartupHub estimates Quince Therapeutics's effective valuation at $644.9M (range $451.4M to $838.4M, 28% confidence), based on comparable companies in the sector.